Ascendis Pharma A/S (ASND)
154.80
-0.31 (-0.20%)
At close: Feb 20, 2025, 3:59 PM
154.58
-0.14%
After-hours: Feb 20, 2025, 04:00 PM EST
Ascendis Pharma A/S Income Statement
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 363.64M | 266.72M | 51.17M | 7.78M | 6.95M | 13.38M | 10.58M | 1.53M | 4.61M | 8.12M | 13.98M | 20.41M | 15.58M |
| Cost of Revenue | 44.26M | 44.40M | 12.14M | 3.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 319.38M | 222.32M | 39.04M | 4.25M | 6.95M | 13.38M | 10.58M | 1.53M | 4.61M | 8.12M | 13.98M | 20.41M | 15.58M |
| Operating Income | -278.76M | -455.54M | -561.81M | -451.79M | -330.62M | -226.72M | -154.76M | -111.54M | -72.92M | -41.83M | -11.99M | 5.28M | 1.51M |
| Interest Income | 14.36M | 16.86M | 52.18M | 692.00K | 1.81M | 17.80M | 4.02M | 923.00K | 123.00K | 13.00K | n/a | n/a | n/a |
| Pretax Income | -373.24M | -474.14M | -577.82M | -383.94M | -419.17M | -218.25M | -130.49M | -124.37M | -68.73M | -33.57M | -10.34M | 4.71M | 1.28M |
| Net Income | -378.08M | -481.45M | -583.19M | -383.58M | -418.95M | -218.02M | -130.10M | -123.90M | -68.50M | -32.92M | -9.66M | 4.08M | 1.25M |
| Selling & General & Admin | 284.55M | 264.41M | 221.23M | 160.18M | 76.67M | 48.47M | 25.06M | 13.48M | 11.50M | 9.41M | 6.27M | 2.42M | 2.69M |
| Research & Development | 307.00M | 413.45M | 379.62M | 295.87M | 260.90M | 191.62M | 140.28M | 99.59M | 66.02M | 40.53M | 19.70M | 12.71M | 11.38M |
| Other Expenses | 6.60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a |
| Operating Expenses | 598.15M | 677.86M | 600.85M | 456.05M | 337.57M | 240.09M | 165.34M | 113.07M | 77.53M | 49.94M | 25.97M | 15.13M | 14.07M |
| Interest Expense | 65.50M | 44.06M | 50.49M | 3.91M | 1.92M | 1.22M | 127.00K | 97.00K | 5.00K | 6.00K | 16.00K | 8.00K | 20.00K |
| Selling & Marketing Expenses | n/a | 5.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 642.40M | 722.26M | 612.99M | 459.57M | 337.57M | 240.09M | 165.34M | 113.07M | 77.53M | 49.94M | 25.97M | 15.13M | 14.07M |
| Income Tax | 4.84M | 7.30M | 5.38M | -367.00K | -219.00K | -234.00K | -394.00K | -477.00K | -227.00K | -652.00K | -682.00K | 626.00K | 35.00K |
| Shares Outstanding (Basic) | 57.35M | 56.29M | 56.07M | 54.77M | 50.62M | 46.51M | 41.09M | 33.63M | 26.56M | 23.68M | 16.94M | 10.80M | 10.80M |
| Shares Outstanding (Diluted) | 57.35M | 56.29M | 56.07M | 54.77M | 50.62M | 46.51M | 41.09M | 33.63M | 26.56M | 23.77M | 16.94M | 10.80M | 10.80M |
| EPS (Basic) | -6.59 | -8.55 | -10.4 | -7 | -8.28 | -4.69 | -3.17 | -3.68 | -2.58 | -1.39 | -0.57 | 0.38 | 0.12 |
| EPS (Diluted) | -6.59 | -8.55 | -10.4 | -7 | -8.28 | -4.69 | -3.17 | -3.68 | -2.58 | -1.39 | -0.57 | 0.38 | 0.12 |
| EBITDA | -290.02M | -411.17M | -556.04M | -423.67M | -328.88M | -217.03M | -150.18M | -109.88M | -72.12M | -33.01M | -11.48M | 5.68M | 1.73M |
| Depreciation & Amortization | 17.71M | 18.91M | 17.63M | 16.00M | 8.80M | 6.67M | 908.17K | 689.46K | 710.02K | 558.00K | 504.00K | 405.00K | 425.00K |